It was concluded that positive FIT results (i.e., elevated f-Hb) are associated with an increased risk of mortality from CRC and, much more importantly, for various other chronic diseases, suggesting that it could be a predictor of mortality independent of its association with CRC. The gene discussed is GSTM1; the disease is colorectal carcinoma.